Get the Stockscreener App
0.4206
4.71%
-0.0208
After Hours:
.43
0.0094
+2.23%
Applied Therapeutics Inc stock is traded at $0.4206, with a volume of 802.20K.
It is down -4.71% in the last 24 hours and down -4.41% over the past month.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.4414
Open:
$0.4307
24h Volume:
802.20K
Relative Volume:
0.55
Market Cap:
$60.57M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
-0.3116
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
-11.25%
1M Performance:
-4.41%
6M Performance:
-19.49%
1Y Performance:
-91.38%
1-Day Range:
$0.4202
$0.445
1-Week Range:
$0.4202
$0.4899
52-Week Range:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Name
Applied Therapeutics Inc
Sector
Industry
Phone
212-220-9226
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Compare APLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.4206 | 64.01M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-02-24 | Downgrade | UBS | Buy → Neutral |
| Nov-29-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-31-24 | Initiated | William Blair | Outperform |
| Mar-26-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-22-24 | Initiated | Leerink Partners | Outperform |
| Jan-04-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Aug-27-21 | Downgrade | Goldman | Neutral → Sell |
| Jun-25-21 | Resumed | Goldman | Neutral |
| Oct-08-20 | Initiated | Truist | Buy |
| Apr-22-20 | Initiated | Goldman | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jun-10-19 | Initiated | Citigroup | Buy |
| Jun-10-19 | Initiated | Cowen | Outperform |
| Jun-10-19 | Initiated | Robert W. Baird | Outperform |
View All
Applied Therapeutics Inc Stock (APLT) Latest News
Important Notice to Long-Term Shareholders of Applied - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Applied Therapeutics, Inc. (APLT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Applied Therapeutics Reports Second Quarter 2025 Financial Results - Investing News Network
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); ... - Bluefield Daily Telegraph
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Investors to Inquire about Securities Investigation - ACCESS Newswire
Applied Therapeutics Announces New Equity Offering Agreement - MSN
Is Applied Therapeutics Inc. gaining market shareJuly 2025 Closing Moves & Safe Capital Growth Plans - خودرو بانک
Why is Applied Therapeutics Inc. stock going downWeekly Stock Summary & Reliable Breakout Stock Forecasts - خودرو بانک
What is the cash position of Applied Therapeutics Inc.2025 Technical Overview & Fast Exit and Entry Strategy Plans - خودرو بانک
How to build a custom watchlist for Applied Therapeutics Inc.2025 Winners & Losers & Verified Technical Signals - Newser
Applied Therapeutics Inc. $APLT Shares Purchased by Propel Bio Management LLC - MarketBeat
Relative strength of Applied Therapeutics Inc. in sector analysis2025 Geopolitical Influence & High Accuracy Investment Signals - Newser
Using AI based signals to follow Applied Therapeutics Inc.Volume Spike & Proven Capital Preservation Methods - Newser
Is Applied Therapeutics Inc. a cyclical or defensive stockWeekly Investment Report & Long Hold Capital Preservation Tips - خودرو بانک
How hedge fund analytics apply to Applied Therapeutics Inc. stock2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
Trend analysis for Applied Therapeutics Inc. this week2025 Analyst Calls & Low Volatility Stock Suggestions - Newser
Should you hold or exit Applied Therapeutics Inc. nowTrade Entry Report & Accurate Technical Buy Alerts - Newser
Long term hold vs stop loss in Applied Therapeutics Inc.July 2025 Sentiment & Accurate Buy Signal Notifications - Newser
Visual analytics tools that track Applied Therapeutics Inc. performance2025 Top Gainers & AI Enhanced Execution Alerts - Newser
Can Applied Therapeutics Inc. grow without external fundingJuly 2025 Drop Watch & Real-Time Buy Signal Alerts - خودرو بانک
Chart based analysis of Applied Therapeutics Inc. trendsLayoff News & Fast Momentum Entry Tips - Newser
Is a relief rally coming for Applied Therapeutics Inc. holders2025 Biggest Moves & Safe Swing Trade Setups - Newser
Will Applied Therapeutics Inc. stock go up soonDay Trade & Expert Approved Trade Ideas - Newser
Can Applied Therapeutics Inc. ride the EV waveWeekly Profit Recap & High Return Stock Watch Alerts - خودرو بانک
Institutional scanner results for Applied Therapeutics Inc.CPI Data & Weekly Top Performers Watchlists - Newser
Pullback Watch: How does Applied Therapeutics Inc. score in quality rankingsDollar Strength & Breakout Confirmation Alerts - خودرو بانک
Applied Therapeutics, Inc. shares fall 2.69% intraday as Smith+Nephew launches CENTRIO PRP System. - AInvest
Published on: 2025-09-03 12:33:27 - Newser
What earnings revisions data tells us about Applied Therapeutics Inc.July 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Aug Analyst Calls: Can Applied Therapeutics Inc. maintain sales growth2025 Pullback Review & Long-Term Growth Portfolio Plans - خودرو بانک
Will Applied Therapeutics Inc. benefit from macro trends2025 Price Targets & Smart Allocation Stock Reports - Newser
Identifying reversal signals in Applied Therapeutics Inc.Quarterly Trade Summary & Weekly High Return Stock Opportunities - Newser
Can Applied Therapeutics Inc. rally from current levelsJuly 2025 Trade Ideas & Safe Capital Growth Plans - Newser
Applied Therapeutics Inc. stock retracement – recovery analysisJuly 2025 Outlook & Free Safe Capital Growth Stock Tips - Newser
Published on: 2025-09-02 23:14:31 - Newser
Sentiment analysis tools applied to Monopar Therapeutics Inc.Market Risk Summary & Growth Focused Investment Plans - Newser
Aug Update: Is Applied Therapeutics Inc. likely to announce a buyback2025 EndofYear Setup & Free Reliable Trade Execution Plans - خودرو بانک
Visual trend scoring systems applied to Dermata Therapeutics Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser
Sentiment analysis tools applied to Edgewise Therapeutics Inc.Portfolio Update Summary & Smart Investment Allocation Insights - Newser
Is Applied Therapeutics Inc. likely to announce a buybackWeekly Trend Recap & Consistent Income Trade Ideas - خودرو بانک
What recovery options are there for Applied Therapeutics Inc.2025 Risk Factors & Expert Approved Trade Ideas - Newser
Live market analysis of Applied Therapeutics Inc.Weekly Gains Report & Free Daily Entry Point Trade Alerts - Newser
Order Flow Trends Show Accumulation in Applied Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Backtesting results for Applied Therapeutics Inc. trading strategiesSell Signal & Free Safe Capital Growth Stock Tips - Newser
Multi factor analysis applied to LENZ Therapeutics Inc.CPI Data & Proven Capital Preservation Methods - Newser
Applied Therapeutics Inc Stock (APLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):